ArticleDrug delivery and translational research2026

Development of silver-based hybrid nanoparticles loaded with eEF2 K-siRNA and quercetin against triple-negative breast cancer.

Orhan Burak Eksi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.